# Cascade Biocatalysts, Inc. — Form D

Cascade Biocatalysts, Inc. of DENVER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-25. The offering totals $5.6M, of which $5.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-08-25
- Form: D
- Accession: 0001231919-25-000162
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.6M
- Amount sold: $5.4M
- Remaining: $175K
- Investors: 41
- Date of first sale: 2025-08-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-555703

## Issuer

- Name: Cascade Biocatalysts, Inc.
- CIK: 0002083126
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 3960 NIAGARA STREET, DENVER, CO, 80207
- Phone: (310) 913-0576

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Jared Campbell | Director | Denver, CO |
| Alexander Rosay | Director | Denver, CO |
| James Weltz | Director | Denver, CO |
| Alexander Rosay | Executive Officer | Denver, CO |
| James Weltz | Executive Officer | Denver, CO |
| Alexander Rosay | Promoter | Denver, CO |
| James Weltz | Promoter | Denver, CO |

## More

- [CIK 2083126 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2083126&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001231919-25-000162.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.